AIC-649

N/A

Report date: 2025/03/18 14:31:22

Base Information

Drug NameAIC-649
Drug Alias NameAIC-649
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Hepatitis B, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth AfricaGermany
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAicurisBayer AG
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Hepatitis B, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A